NCT04002726

Brief Summary

Trachomatous inflammation-follicular (TF) is diagnosed by looking for clinical signs of infection of everted eyelids (conjunctivae) of children. The overall objective of this project is to investigate the effectiveness, acceptability and feasibility of an app-based versus slide-based IGA for trachoma graders. Fieldwork will take place during routine Tropical Data trainings. A non-inferiority randomised controlled trial design will be employed, with grader trainees randomised to app- or slide-based training, and then to app- or slide-based IGA testing. The training and IGA testing method will be compared with field IGA test score to determine which method best predicts passing the field IGA test.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2019

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 19, 2019

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 1, 2019

Completed
7 days until next milestone

Study Start

First participant enrolled

July 8, 2019

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 12, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 12, 2019

Completed
Last Updated

August 22, 2022

Status Verified

May 1, 2022

Enrollment Period

4 days

First QC Date

June 19, 2019

Last Update Submit

August 18, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Classroom IGA success

    The proportion of participants successfully passing (kappa ≥0.7) the app-based IGA.

    1 day

  • Classroom IGA success

    The proportion of participants successfully passing (kappa ≥0.7) the slide-based IGA.

    1 day

  • Field IGA success

    The correlation between classroom IGA score and field IGA score

    3 days

  • Field IGA success

    The proportion of participants who successfully pass the classroom IGA test (kappa ≥0.7) who also successfully pass the field-based IGA test (kappa ≥0.7)

    3 days

Secondary Outcomes (6)

  • Trainee characteristics

    5 days

  • Trainee characteristics

    5 days

  • Acceptability and feasibility (common themes from focus group discussions) of app versus slide-based training.

    45 minutes

  • Acceptability and feasibility (common themes from focus group discussions) of app versus slide-based IGA testing.

    45 minutes

  • Cost of app versus slide-based training

    5 days

  • +1 more secondary outcomes

Study Arms (4)

Group Aa

ACTIVE COMPARATOR

Allocated to do the app-based training. Allocated to do the app-based classroom IGA test first, and the slide-based test second.

Other: Inter-grader agreement (IGA) app

Group As

ACTIVE COMPARATOR

Allocated to do the app-based training. Allocated to do the slide-based classroom IGA test first, and the app-based test second.

Other: Inter-grader agreement (IGA) app

Group Sa

ACTIVE COMPARATOR

Allocated to do the slide-based training. Allocated to do the app-based classroom IGA test first, and the slide-based test second.

Other: Inter-grader agreement (IGA) app

Group Ss

ACTIVE COMPARATOR

Allocated to do the app-based training. Allocated to do the slide-based classroom IGA test first, and the app-based test second.

Other: Inter-grader agreement (IGA) app

Interventions

A smartphone-based app with images of conjunctivae for trachoma grading training purposes.

Group AaGroup AsGroup SaGroup Ss

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Arusha region

Arusha, Tanzania

Location

MeSH Terms

Conditions

Trachoma

Interventions

Immunoglobulin AAmyloid

Condition Hierarchy (Ancestors)

Conjunctivitis, BacterialEye Infections, BacterialBacterial InfectionsBacterial Infections and MycosesInfectionsChlamydia InfectionsChlamydiaceae InfectionsGram-Negative Bacterial InfectionsEye InfectionsConjunctivitisConjunctival DiseasesEye DiseasesCorneal Diseases

Intervention Hierarchy (Ancestors)

Immunoglobulin IsotypesAntibodiesImmunoglobulinsImmunoproteinsBlood ProteinsProteinsAmino Acids, Peptides, and ProteinsSerum GlobulinsGlobulinsMultiprotein ComplexesMacromolecular Substances

Study Officials

  • Emma Harding-Esch

    London School of Hygiene and Tropical Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 19, 2019

First Posted

July 1, 2019

Study Start

July 8, 2019

Primary Completion

July 12, 2019

Study Completion

July 12, 2019

Last Updated

August 22, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will share

Anonymised data will be shared with relevant study team members for the purposes of data analysis. Data Transfer Agreements will be completed, where appropriate.

Shared Documents
STUDY PROTOCOL
Time Frame
Data will be shared with team members as they are collected.
Access Criteria
Data access requests from outside the study team for the specified data analyses will be reviewed by the Principal Investigator. Requestors will be required to sign a Data Access Agreement.

Locations